Announcements Trials
Browse Landscape

Phase

Phase 1/2 1Phase 1 1

Status

Recruiting 2

Sponsor Class

NIH 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Leukemia, Myeloid, Acute 47Precursor Cell Lymphoblastic Leukemia-Lymphoma 32Myelodysplastic Syndromes 27Multiple Myeloma 20Recurrence 19Lymphoma, Non-Hodgkin 15Lymphoma, B-Cell 14Lymphoma 14Leukemia, Lymphocytic, Chronic, B-Cell 13Ovarian Neoplasms 12Hematologic Neoplasms 12Melanoma 11Pancreatic Neoplasms 10Myeloproliferative Disorders 10Burkitt Lymphoma 10Leukemia 9Hodgkin Disease 9Stomach Neoplasms 8Lymphoma, Large B-Cell, Diffuse 8Leukemia, Myelogenous, Chronic, BCR-ABL Positive 8Leukemia, Biphenotypic, Acute 8Neoplasms 7Leukemia, Myelomonocytic, Chronic 7Colorectal Neoplasms 7Triple Negative Breast Neoplasms 6Osteosarcoma 6Neuroblastoma 6Neoplasm Metastasis 6Lymphoma, Mantle-Cell 6Lymphoma, Follicular 6

Interventions

durvalumab 9Bevacizumab 8tremelimumab 4lenvatinib 3atezolizumab 3Nivolumab 3Ipilimumab 3fludarabine 2Magnetic Resonance Imaging 2Hepatectomy 2Gemcitabine 2Cyclophosphamide 2Cisplatin 2trastuzumab deruxtecan 1toripalimab 1ropidoxuridine 1poly ICLC 1pembrolizumab 1brodalumab 1X-Rays 1Whole Genome Sequencing 1Technetium Tc 99m Aggregated Albumin 1Standard of Care 1Specimen Handling 1Radiotherapy, Intensity-Modulated 1Radiotherapy 1Radiosurgery 1Radionuclide Imaging 1Pregabalin 1Pluvicto 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Liver Neoplasms × fludarabine × 90 days × Clear all
NCT05003895 2026-04-07

GPC3 Targeted CAR-T Cell Therapy in Advanced GPC3 Expressing Solid Tumor Malignancies

National Institutes of Health Clinical Center (CC)

Phase 1 Recruiting
38 enrolled
Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT07500220 2026-03-30

DUET-HCC

Beijing Biotech

Phase 1/2 Recruiting
30 enrolled
Gastrointestinal

Simpson-Golabi-Behmel syndrome, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡